A decrease in signaling through the RAS-mitogen-activated protein kinase (MAPK) pathway contributes to decreased DNMT activity and DNA hypomethylation in T cells from patients with active SLE [85]. This evidence concerns the gene WNK2 and systemic lupus erythematosus.